Abstract

Two simple, accurate, and precise UV derivative spectrophotometric methods for the simultaneous determination of Prasugrel and Aspirin in synthetic mixture form have been developed. The first method involves measurement of second order derivative spectra of Prasugrel and Aspirin. The zero crossing wavelengths 267.62 nm and 252.40 nm were selected for estimation of Prasugrel and Aspirin, respectively. In the second method, the first order derivatives of ratio spectra were calculated and used for the determination of Prasugrel and Aspirin by measuring the peak intensity at 268 nm and 290 nm, respectively. The methods were validated as per the ICH guideline Q2 (R1). Beer’s law is followed in the range of 5–45 μg/mL for Prasugrel and 25–150 μg/mL for Aspirin by second order derivative method and 6–22 μg/mL for Prasugrel and 45–165 μg/mL for Aspirin by ratio first order derivative method. The recovery studies confirmed the accuracy of the methods. Relative standard deviations for repeatability and inter- and intraday assays were less than 2%. Hence, the described derivative spectrophotometric methods are simple, accurate, precise, and excellent alternatives to sophisticated chromatographic techniques and can be potentially used for the simultaneous determination of Prasugrel and Aspirin in combined dosage form.

Highlights

  • Aspirin (ASP), 2-(acetyloxy)benzoic acid, (Figure 1) has antiinflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins

  • Second order derivative method was used in the present work

  • The results showed that the % recovery values are within the acceptable limits with low standard deviation indicating high accuracy of the proposed analytical methods

Read more

Summary

Introduction

Aspirin (ASP), 2-(acetyloxy)benzoic acid, (Figure 1) has antiinflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. It inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis [1]. R-138727 irreversibly binds to P2Y12 type ADP receptors on platelets thereby inhibiting ADPmediated platelet activation and aggregation [5]. It is not official in any pharmacopoeia. Aspirin in combination with Prasugrel is used to prevent thrombotic complications of Acute Coronary Syndrome (ACS) and percutaneous coronary intervention (PCI) [6]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call